BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 25953675)

  • 1. Use of the Impella 2.5 left ventricular assist device in a patient with cardiogenic shock secondary to takotsubo cardiomyopathy.
    Rashed A; Won S; Saad M; Schreiber T
    BMJ Case Rep; 2015 May; 2015():. PubMed ID: 25953675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanical Circulatory Support With Impella Percutaneous Ventricular Assist Device as a Bridge to Recovery in Takotsubo Syndrome Complicated by Cardiogenic Shock and Left Ventricular Outflow Tract Obstruction.
    Beneduce A; Fausta Bertoldi L; Melillo F; Baldetti L; Spoladore R; Slavich M; Oppizzi M; Margonato A; Pappalardo F
    JACC Cardiovasc Interv; 2019 Feb; 12(4):e31-e32. PubMed ID: 30711550
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful use of the impella ventricular assist device for management of reverse Takotsubo Cardiomyopathy in the setting of acute intracranial hemorrhage.
    Barsoum E; Elhosseiny S; Patel B; Pathak S; Patel A; Vaidya P
    Heart Lung; 2021; 50(2):313-315. PubMed ID: 33482434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of an argatroban-based purge solution in a percutaneous ventricular assist device.
    Laliberte B; Reed BN
    Am J Health Syst Pharm; 2017 May; 74(9):e163-e169. PubMed ID: 28438820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thirty-five day Impella 5.0 support via right axillary side graft cannulation for acute cardiogenic shock.
    Castillo-Sang MA; Prasad SM; Singh J; Ewald GA; Silvestry SC
    Innovations (Phila); 2013; 8(4):307-9. PubMed ID: 24145977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of cardiogenic shock due to Takotsubo syndrome with implantation of a temporary microaxial left ventricular assist device in transaxillary approach.
    von Mackensen JKR; Shazly AE; Schoenrath F; Kempfert J; Starck CT; Potapov EV; Jacobs S; Falk V; Wert L
    J Cardiothorac Surg; 2023 Nov; 18(1):343. PubMed ID: 38012790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management and outcome of patients supported with Impella 5.0 for refractory cardiogenic shock.
    Gaudard P; Mourad M; Eliet J; Zeroual N; Culas G; Rouvière P; Albat B; Colson P
    Crit Care; 2015 Oct; 19():363. PubMed ID: 26453047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term mechanical circulatory support with the Impella 5.0 device for cardiogenic shock at La Pitié-Salpêtrière.
    Mastroianni C; Bouabdallaoui N; Leprince P; Lebreton G
    Eur Heart J Acute Cardiovasc Care; 2017 Feb; 6(1):87-92. PubMed ID: 26873912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Impella Recover 2.5 left ventricular assist device in patients with cardiogenic shock or undergoing high-risk percutaneous coronary intervention procedures: experience of a high-volume center.
    Vecchio S; Chechi T; Giuliani G; Lilli A; Consoli L; Spaziani G; Giannotti F; Margheri M
    Minerva Cardioangiol; 2008 Aug; 56(4):391-9. PubMed ID: 18614983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Favorable Effects of Impella on Takotsubo Syndrome Complicated with Cardiogenic Shock.
    Nishikawa R; Nagano N; Kokubu N; Hashimoto K; Nakata J; Kishiue N; Takahashi R; Otomo S; Tsuchihashi K; Yano T
    Int Heart J; 2021 Nov; 62(6):1430-1435. PubMed ID: 34789645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous left-ventricular support with the Impella-2.5-assist device in acute cardiogenic shock: results of the Impella-EUROSHOCK-registry.
    Lauten A; Engström AE; Jung C; Empen K; Erne P; Cook S; Windecker S; Bergmann MW; Klingenberg R; Lüscher TF; Haude M; Rulands D; Butter C; Ullman B; Hellgren L; Modena MG; Pedrazzini G; Henriques JP; Figulla HR; Ferrari M
    Circ Heart Fail; 2013 Jan; 6(1):23-30. PubMed ID: 23212552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Impella heart pump for management of women with peripartum cardiogenic shock.
    Elkayam U; Schäfer A; Chieffo A; Lansky A; Hall S; Arany Z; Grines C
    Clin Cardiol; 2019 Oct; 42(10):974-981. PubMed ID: 31436333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction.
    Seyfarth M; Sibbing D; Bauer I; Fröhlich G; Bott-Flügel L; Byrne R; Dirschinger J; Kastrati A; Schömig A
    J Am Coll Cardiol; 2008 Nov; 52(19):1584-8. PubMed ID: 19007597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Initial experience with the Impella left ventricular assist device for postcardiotomy cardiogenic shock and unprotected left coronary artery angioplasty in patients with a low left ventricular ejection fraction].
    Bautista-Hernández V; Gutiérrez F; Pinar E; Gimeno JR; Arribas JM; García-Puente J; Ray VG; Arcas R; Valdés M
    Rev Esp Cardiol; 2007 Sep; 60(9):984-7. PubMed ID: 17915156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of Takotsubo cardiomyopathy with cardiogenic shock after influenza infection successfully recovered by IMPELLA support.
    Nakamura M; Nakagaito M; Hori M; Ueno H; Kinugawa K
    J Artif Organs; 2019 Dec; 22(4):330-333. PubMed ID: 31228028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanical circulatory support with the Impella 5.0 device for postcardiotomy cardiogenic shock: a three-center experience.
    Engström AE; Granfeldt H; Seybold-Epting W; Dahm M; Cocchieri R; Driessen AH; Sjauw KD; Vis MM; Baan J; Koch KT; De Jong M; Lagrand WK; Van Der Sloot JA; Tijssen JG; De Winter RJ; De Mol BA; Piek JJ; Henriques JP
    Minerva Cardioangiol; 2013 Oct; 61(5):539-46. PubMed ID: 24096248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of the impella device for acute mechanical circulatory support.
    Lemaire A; Anderson MB; Prendergast T; Stockmaster N; Goodman A; Lozane AM; Batsides G
    Innovations (Phila); 2013; 8(1):12-6. PubMed ID: 23571788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute pancreatitis-induced takotsubo cardiomyopathy and cardiogenic shock treated with a percutaneous left ventricular assist device.
    Koop AH; Bailey RE; Lowman PE
    BMJ Case Rep; 2018 Oct; 2018():. PubMed ID: 30317201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impella Mechanical Circulatory Support for Takotsubo Syndrome With Shock: A Retrospective Multicenter Analysis.
    Napp LC; Westenfeld R; Møller JE; Pappalardo F; Ibrahim K; Bonello L; Wilkins C; Pershad A; Mannino SF; Schreiber TL; Hall PA; Medjamia AM; Haurand JM; Sieweke JT; Schäfer A; Grines CL; Burkhoff D; Moses JW; Ohman EM; O'Neill WW; Kapur NK; Bauersachs J
    Cardiovasc Revasc Med; 2022 Jul; 40():113-119. PubMed ID: 34916157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impella device for acute mechanical circulatory support in patients in cardiogenic shock.
    Lemaire A; Anderson MB; Lee LY; Scholz P; Prendergast T; Goodman A; Lozano AM; Spotnitz A; Batsides G
    Ann Thorac Surg; 2014 Jan; 97(1):133-8. PubMed ID: 24090575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.